Diabetic Retinopathy: From Animal Models to Cellular Signaling

Int J Mol Sci. 2022 Jan 27;23(3):1487. doi: 10.3390/ijms23031487.

Abstract

Diabetic retinopathy (DR) is an ocular complication of diabetes mellitus (DM), a metabolic disorder characterized by elevation in blood glucose level. The pathogenesis of DR includes vascular, neuronal, and inflammatory components leading to activation of complex cellular molecular signaling. If untreated, the disease can culminate in vision loss that eventually leads to blindness. Animal models mimicking different aspects of DM complications have been developed to study the development and progression of DR. Despite the significant contribution of the developed DR models to discovering the mechanisms of DR and the recent achievements in the research field, the sequence of cellular events in diabetic retinas is still under investigation. Partially, this is due to the complexity of molecular mechanisms, although the lack of availability of models that adequately mimic all the neurovascular pathobiological features observed in patients has also contributed to the delay in determining a precise molecular trigger. In this review, we provide an update on the status of animal models of DR to help investigators choose an appropriate system to validate their hypothesis. We also discuss the key cellular and physiological events of DR in these models.

Keywords: animal models of diabetes; cellular signaling of diabetic retina; diabetic retina; electrophysiology of diabetic retina; tribbles homolog 3 protein.

Publication types

  • Review

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / metabolism*
  • Diabetes Mellitus, Experimental / pathology
  • Diabetes Mellitus, Experimental / therapy
  • Diabetic Retinopathy / metabolism*
  • Diabetic Retinopathy / pathology
  • Diabetic Retinopathy / therapy
  • Humans
  • Retina / metabolism*
  • Signal Transduction*